Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3132)	3/19/2001 7:27:06 PM
From: Michael Young	Respond to of 52153

<<Hard to know at this point whether to go with the beaten-down long-term stories like MLNM and SEPR, or jump on the stocks with better relative short-term performance.>> In the short term the crushed stocks should provide nice bounces. But longer term I'd rather be in stuff like SCIO and KOSP. In fact, those are the only bio stocks I own. And only because the market caps are low relative to the upcoming approvals this year. And the fact that the momo funds aren't involved (yet) helps a lot. MIKE